100.96
전일 마감가:
$100.94
열려 있는:
$100.95
하루 거래량:
880.80K
Relative Volume:
1.83
시가총액:
$3.32B
수익:
$2.32B
순이익/손실:
$82.93M
주가수익비율:
40.06
EPS:
2.52
순현금흐름:
$203.54M
1주 성능:
+2.50%
1개월 성능:
+3.89%
6개월 성능:
+9.12%
1년 성능:
+3.28%
아메디시스 Stock (AMED) Company Profile
명칭
Amedisys Inc
전화
(225) 292-2031
주소
3854 AMERICAN WAY, BATON ROUGE, LA
AMED을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
AMED
Amedisys Inc
|
100.96 | 3.32B | 2.32B | 82.93M | 203.54M | 2.52 |
![]()
HCA
Hca Healthcare Inc
|
382.91 | 89.29B | 72.70B | 5.97B | 7.29B | 23.79 |
![]()
THC
Tenet Healthcare Corp
|
166.63 | 14.63B | 20.52B | 1.46B | 1.41B | 15.12 |
![]()
FMS
Fresenius Medical Care Ag Adr
|
24.11 | 14.12B | 20.92B | 666.06M | 1.85B | 1.1422 |
![]()
EHC
Encompass Health Corp
|
117.44 | 11.84B | 5.51B | 494.70M | 386.40M | 4.84 |
![]()
UHS
Universal Health Services Inc
|
171.66 | 11.10B | 16.08B | 1.20B | 1.06B | 17.82 |
아메디시스 Stock (AMED) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-07-29 | 다운그레이드 | Deutsche Bank | Buy → Hold |
2024-07-01 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
2023-06-07 | 다운그레이드 | Truist | Buy → Hold |
2023-04-21 | 개시 | Cantor Fitzgerald | Neutral |
2023-03-13 | 개시 | Barclays | Equal Weight |
2022-10-27 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
2022-08-02 | 다운그레이드 | UBS | Neutral → Sell |
2022-06-29 | 개시 | Stifel | Hold |
2022-06-21 | 다운그레이드 | BofA Securities | Neutral → Underperform |
2022-03-01 | 업그레이드 | UBS | Sell → Neutral |
2022-02-25 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
2022-02-25 | 재확인 | Credit Suisse | Outperform |
2022-02-25 | 재확인 | Oppenheimer | Outperform |
2022-02-25 | 재확인 | RBC Capital Mkts | Outperform |
2022-02-25 | 재확인 | Raymond James | Outperform |
2022-02-25 | 재확인 | Truist | Buy |
2021-09-27 | 개시 | SVB Leerink | Mkt Perform |
2021-09-24 | 개시 | UBS | Sell |
2021-09-10 | 개시 | Cowen | Market Perform |
2021-08-10 | 재확인 | The Benchmark Company | Buy |
2021-08-05 | 다운그레이드 | BofA Securities | Buy → Neutral |
2020-08-20 | 재개 | Barclays | Overweight |
2020-07-30 | 재확인 | The Benchmark Company | Buy |
2020-06-18 | 업그레이드 | The Benchmark Company | Hold → Buy |
2020-05-07 | 다운그레이드 | The Benchmark Company | Buy → Hold |
2020-03-09 | 업그레이드 | The Benchmark Company | Hold → Buy |
2020-01-17 | 개시 | Credit Suisse | Outperform |
2019-11-01 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
2019-10-22 | 재개 | Stephens | Equal-Weight |
2019-09-17 | 개시 | Deutsche Bank | Buy |
2019-05-02 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
2018-12-14 | 개시 | Barclays | Equal Weight |
2018-11-16 | 개시 | UBS | Neutral |
2018-10-30 | 업그레이드 | The Benchmark Company | Hold → Buy |
2018-07-03 | 업그레이드 | BofA/Merrill | Neutral → Buy |
2018-03-19 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
2017-11-09 | 재확인 | RBC Capital Mkts | Sector Perform |
2017-11-09 | 다운그레이드 | The Benchmark Company | Buy → Hold |
2017-11-08 | 재확인 | Mizuho | Buy |
2017-11-02 | 업그레이드 | The Benchmark Company | Hold → Buy |
2017-08-21 | 개시 | BofA/Merrill | Neutral |
모두보기
아메디시스 주식(AMED)의 최신 뉴스
What's Going On With UnitedHealth Stock Monday? - Benzinga
DOJ: UHG, Amedisys Must Divest 164 Locations for Acquisition to Proceed - Dealbreaker
Justice Department to require UnitedHealth Group divestitures in Amedisys acquisition - Financial Regulation News -
Amedisys stock reaches 52-week high at 100.99 USD By Investing.com - Investing.com Canada
Amedisys stock reaches 52-week high at 100.99 USD - Investing.com
UnitedHealth’s $3.3bn Amedisys deal faces strict divestiture terms - Yahoo Finance
Institutional Tools Highlight Unusual Flow in Amedisys Inc.Reversal Alert Based on RSI Indicator Confirmed - metal.it
DOJ Requires Broad Divestitures, $1.1M Fine To Resolve UnitedHealth-Amedisys Merger Challenge: Retail Thinks It May Reduce Expected Synergies - MSN
Maryland Among States in $3.3B UnitedHealth–Amedisys Antitrust Agreement - The MoCo Show -
Amedisys and UnitedHealth Settle with DOJ Over Acquisition - AInvest
DOJ Divestiture Remedy Opens Door for $3.3B Hospice Merger Plan Between UnitedHealth Group and Amedisys - Law.com
UnitedHealth Surges to 23rd in Trading Volume as Amedisys Acquisition Drives Home Health Industry Consolidation - AInvest
Amedisys fined $1.1 million by US DOJ for HSR Act violations - MLex
UnitedHealth Group Inc. to Divest 164 Locations in Proposed Settlement Over Amedisys Acquisition - Hoodline
DOJ proposes settlement to clear way for $3.3B UnitedHealth-Amedisys deal - The Business Journals
UnitedHealth Agrees to Divest Over 160 Healthcare Facilities in $3.3B Amedisys Deal Settlement - AInvest
Why Is UnitedHealth Stock Trading Higher TodayAmedisys (NASDAQ:AMED), UnitedHealth Group (NYSE:UNH) - Benzinga
UnitedHealth, Amedisys merger appears set to close post-DOJ settlement - Healthcare Dive
O’Fallon Home Health Site Included in UnitedHealth Antitrust Divestiture - RiverBender.com
UnitedHealth and Amedisys $3.3B Merger Clears DOJ Hurdle with Major Conditions - AInvest
UnitedHealth's Acquisition of Amedisys: Hold Rating Maintained Amid Settlement Progress - AInvest
Justice Department Requires Broad Divestitures to Resolve Challenge to UnitedHealth’s Acquisition of Amedisys - EIN News
DOJ greenlights UnitedHealth/Amedisys with divestitures - Global Competition Review
O'Fallon Facility To Be Divested: Attorney General Raoul Announces Proposed Settlement To Resolve Challenge To UnitedHealth’s Acquisition Of Amedisys - RiverBender.com
UnitedHealth-Amedisys settlement with US DOJ requires divestitures, fine - MLex
AELP says UnitedHealth Group-Amedisys settlement a loss for hospice patients, nurses - MLex
UnitedHealth to sell off 164 locations to settle US challenge to Amedisys deal - Reuters
UnitedHealth, Amedisys Reach Settlement With DOJ Over Proposed Merger - 富途牛牛
Hold Rating Maintained Amid Settlement Progress in UnitedHealth’s Acquisition of Amedisys - TipRanks
UnitedHealth and Amedisys reach settlement with DOJ over $3.3B merger - Healthcare Dive
DOJ Oks UnitedHealth, Amedisys deal on divestiture conditions - TechTarget
UnitedHealth (UNH)-Amedisys $3.3B Merger Approved with Major DOJ Conditions - TipRanks
Amedisys shares rise 1.60% intraday after UnitedHealth and Amedisys reach settlement with DOJ. - AInvest
Justice Department Requires Broad Divestitures To Resolve Challenge To UnitedHealth's Acquisition of Amedisys - 富途牛牛
UnitedHealth to sell off 164 locations to settle US challenge to Amedisys deal | Business Information & News | FE - Westlaw Today
UnitedHealth Group, Amedisys reach merger settlement with DOJ - Modern Healthcare
UnitedHealth's Amedisys Merger: Navigating Divestitures and Shareholder Value - AInvest
Amedisys Inc and Unitedhealth agree to proposed final judgment - MarketScreener
US DOJ requires divestitures to resolve challenge to UnitedHealth’s acquisition of Amedisys - MLex
UnitedHealth to Divest 164 Facilities in Amedisys Acquisition Settlement - AInvest
[UPDATED] DOJ to Clear Way for Amedisys, UnitedHealth Group Transaction - Hospice News
DOJ to Require Broad Divestitures to Resolve Challenge to UnitedHealth's Acquisition of Amedisys - Morningstar
UnitedHealth Selling Home Health Branches In DOJ Deal - Law360
Amedisys and UnitedHealth Resolve Merger Opposition - TipRanks
Amedisys (AMED) Settles with DOJ Over $3.3 Billion UnitedHealth Deal - GuruFocus
UnitedHealth, Amedisys Reach Tentative Merger Deal With DOJ - Bloomberg.com
US Justice Dept. says broad divestitures required to resolve challenge to Unitedhealth’s acquisition of Amedisys - Reuters
[8-K] Amedisys Inc Reports Material Event | AMED SEC FilingForm 8-K - Stock Titan
Amedisys gains on settlement with DOJ over sale to UnitedHealth (update) (AMED:NASDAQ) - Seeking Alpha
Oppenheimer Maintains Hold Rating on Amedisys Amidst Insider Activity - AInvest
Amedisys, Inc. Reports Strong Q2 2025 Revenue Growth - TipRanks
아메디시스 (AMED) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):